Matches in SemOpenAlex for { <https://semopenalex.org/work/W3031193402> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W3031193402 endingPage "2170" @default.
- W3031193402 startingPage "2162" @default.
- W3031193402 abstract "Abstract Laminin-α2 related congenital muscular dystrophy (LAMA2-CMD) is a fatal muscle disease caused by mutations in the LAMA2 gene. Laminin-α2 is critical for the formation of laminin-211 and -221 heterotrimers in the muscle basal lamina. LAMA2-CMD patients exhibit hypotonia from birth and progressive muscle loss that results in developmental delay, confinement to a wheelchair, respiratory insufficiency and premature death. There is currently no cure or effective treatment for LAMA2-CMD. Several studies have shown laminin-111 can serve as an effective protein-replacement therapy for LAMA2-CMD. Studies have demonstrated early treatment with laminin-111 protein results in an increase in life expectancy and improvements in muscle pathology and function. Since LAMA2-CMD patients are often diagnosed after advanced disease, it is unclear if laminin-111 protein therapy at an advanced stage of the disease can have beneficial outcomes. In this study, we tested the efficacy of laminin-111 protein therapy after disease onset in a mouse model of LAMA2-CMD. Our results showed laminin-111 treatment after muscle disease onset increased life expectancy, promoted muscle growth and increased muscle stiffness. Together these studies indicate laminin-111 protein therapy either early or late in the disease process could serve as an effective protein replacement therapy for LAMA2-CMD." @default.
- W3031193402 created "2020-06-05" @default.
- W3031193402 creator A5018885173 @default.
- W3031193402 creator A5023493918 @default.
- W3031193402 creator A5047023495 @default.
- W3031193402 creator A5053463226 @default.
- W3031193402 creator A5058900096 @default.
- W3031193402 creator A5067745953 @default.
- W3031193402 creator A5068524064 @default.
- W3031193402 date "2020-05-29" @default.
- W3031193402 modified "2023-10-15" @default.
- W3031193402 title "Laminin-111 protein therapy after disease onset slows muscle disease in a mouse model of laminin-α2 related congenital muscular dystrophy" @default.
- W3031193402 cites W1492942312 @default.
- W3031193402 cites W1971466959 @default.
- W3031193402 cites W1989689747 @default.
- W3031193402 cites W2001282055 @default.
- W3031193402 cites W2019160367 @default.
- W3031193402 cites W2027745468 @default.
- W3031193402 cites W2047015778 @default.
- W3031193402 cites W2050170351 @default.
- W3031193402 cites W2072475154 @default.
- W3031193402 cites W2077802763 @default.
- W3031193402 cites W2087248324 @default.
- W3031193402 cites W2139521871 @default.
- W3031193402 cites W2143987989 @default.
- W3031193402 cites W2166894867 @default.
- W3031193402 cites W2178588157 @default.
- W3031193402 cites W2190700128 @default.
- W3031193402 cites W2491459121 @default.
- W3031193402 cites W2619327564 @default.
- W3031193402 cites W2791349152 @default.
- W3031193402 cites W2809533050 @default.
- W3031193402 cites W2941875406 @default.
- W3031193402 doi "https://doi.org/10.1093/hmg/ddaa104" @default.
- W3031193402 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7526790" @default.
- W3031193402 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32472139" @default.
- W3031193402 hasPublicationYear "2020" @default.
- W3031193402 type Work @default.
- W3031193402 sameAs 3031193402 @default.
- W3031193402 citedByCount "4" @default.
- W3031193402 countsByYear W30311934022021 @default.
- W3031193402 countsByYear W30311934022023 @default.
- W3031193402 crossrefType "journal-article" @default.
- W3031193402 hasAuthorship W3031193402A5018885173 @default.
- W3031193402 hasAuthorship W3031193402A5023493918 @default.
- W3031193402 hasAuthorship W3031193402A5047023495 @default.
- W3031193402 hasAuthorship W3031193402A5053463226 @default.
- W3031193402 hasAuthorship W3031193402A5058900096 @default.
- W3031193402 hasAuthorship W3031193402A5067745953 @default.
- W3031193402 hasAuthorship W3031193402A5068524064 @default.
- W3031193402 hasBestOaLocation W30311934022 @default.
- W3031193402 hasConcept C126322002 @default.
- W3031193402 hasConcept C134018914 @default.
- W3031193402 hasConcept C189165786 @default.
- W3031193402 hasConcept C2779030066 @default.
- W3031193402 hasConcept C2779768179 @default.
- W3031193402 hasConcept C2779814568 @default.
- W3031193402 hasConcept C71924100 @default.
- W3031193402 hasConcept C86803240 @default.
- W3031193402 hasConcept C95444343 @default.
- W3031193402 hasConceptScore W3031193402C126322002 @default.
- W3031193402 hasConceptScore W3031193402C134018914 @default.
- W3031193402 hasConceptScore W3031193402C189165786 @default.
- W3031193402 hasConceptScore W3031193402C2779030066 @default.
- W3031193402 hasConceptScore W3031193402C2779768179 @default.
- W3031193402 hasConceptScore W3031193402C2779814568 @default.
- W3031193402 hasConceptScore W3031193402C71924100 @default.
- W3031193402 hasConceptScore W3031193402C86803240 @default.
- W3031193402 hasConceptScore W3031193402C95444343 @default.
- W3031193402 hasFunder F4320332161 @default.
- W3031193402 hasIssue "13" @default.
- W3031193402 hasLocation W30311934021 @default.
- W3031193402 hasLocation W30311934022 @default.
- W3031193402 hasOpenAccess W3031193402 @default.
- W3031193402 hasPrimaryLocation W30311934021 @default.
- W3031193402 hasRelatedWork W1066822 @default.
- W3031193402 hasRelatedWork W15059093 @default.
- W3031193402 hasRelatedWork W22907737 @default.
- W3031193402 hasRelatedWork W23755275 @default.
- W3031193402 hasRelatedWork W24695398 @default.
- W3031193402 hasRelatedWork W29000202 @default.
- W3031193402 hasRelatedWork W3178499 @default.
- W3031193402 hasRelatedWork W5356161 @default.
- W3031193402 hasRelatedWork W5894301 @default.
- W3031193402 hasRelatedWork W638902 @default.
- W3031193402 hasVolume "29" @default.
- W3031193402 isParatext "false" @default.
- W3031193402 isRetracted "false" @default.
- W3031193402 magId "3031193402" @default.
- W3031193402 workType "article" @default.